Literature DB >> 23460140

What's new in glucose control in the ICU?

Greet Van den Berghe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23460140     DOI： 10.1007/s00134-013-2874-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  16 in total

1.  Tight glycemic control reduces infection and improves neurological outcome in critically ill neurosurgical and neurological patients.

Authors:  Yinn Cher Ooi; T Forcht Dagi; Mitchell Maltenfort; Fred Rincon; Matthew Vibbert; Pascal Jabbour; L Fernando Gonzalez; Robert Rosenwasser; Jack Jallo
Journal:  Neurosurgery       Date:  2012-09       Impact factor: 4.654

Review 2.  Intensive insulin therapy in the ICU--reconciling the evidence.

Authors:  Greet Van den Berghe
Journal:  Nat Rev Endocrinol       Date:  2012-02-07       Impact factor: 43.330

3.  Intensive versus conventional glucose control in critically ill patients.

Authors:  Simon Finfer; Dean R Chittock; Steve Yu-Shuo Su; Deborah Blair; Denise Foster; Vinay Dhingra; Rinaldo Bellomo; Deborah Cook; Peter Dodek; William R Henderson; Paul C Hébert; Stephane Heritier; Daren K Heyland; Colin McArthur; Ellen McDonald; Imogen Mitchell; John A Myburgh; Robyn Norton; Julie Potter; Bruce G Robinson; Juan J Ronco
Journal:  N Engl J Med       Date:  2009-03-24       Impact factor: 91.245

4.  A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study.

Authors:  Jean-Charles Preiser; Philippe Devos; Sergio Ruiz-Santana; Christian Mélot; Djillali Annane; Johan Groeneveld; Gaetano Iapichino; Xavier Leverve; Gérard Nitenberg; Pierre Singer; Jan Wernerman; Michael Joannidis; Adela Stecher; René Chioléro
Journal:  Intensive Care Med       Date:  2009-07-28       Impact factor: 17.440

5.  Impact of hyperglycemia on neuropathological alterations during critical illness.

Authors:  Romain Sonneville; Heleen M den Hertog; Fabian Güiza; Jan Gunst; Inge Derese; Pieter J Wouters; Jean-Philippe Brouland; Andrea Polito; Françoise Gray; Fabrice Chrétien; Philippe Charlier; Djillali Annane; Tarek Sharshar; Greet Van den Berghe; Ilse Vanhorebeek
Journal:  J Clin Endocrinol Metab       Date:  2012-03-22       Impact factor: 5.958

6.  Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial.

Authors:  Dieter Mesotten; Marijke Gielen; Caroline Sterken; Kirsten Claessens; Greet Hermans; Dirk Vlasselaers; Jurgen Lemiere; Lieven Lagae; Marc Gewillig; Benedicte Eyskens; Ilse Vanhorebeek; Pieter J Wouters; Greet Van den Berghe
Journal:  JAMA       Date:  2012-10-24       Impact factor: 56.272

7.  15-year follow-up of recurrent "hypoglycemia" in preterm infants.

Authors:  Win Tin; Greta Brunskill; Tom Kelly; Susan Fritz
Journal:  Pediatrics       Date:  2012-11-05       Impact factor: 7.124

8.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

9.  Tight glycemic control versus standard care after pediatric cardiac surgery.

Authors:  Michael S D Agus; Garry M Steil; David Wypij; John M Costello; Peter C Laussen; Monica Langer; Jamin L Alexander; Lisa A Scoppettuolo; Frank A Pigula; John R Charpie; Richard G Ohye; Michael G Gaies
Journal:  N Engl J Med       Date:  2012-09-07       Impact factor: 91.245

10.  Continuous insulin administration via complex central venous catheter infusion tubing is another risk factor for blood glucose imbalance. A retrospective study.

Authors:  Eric Maury; Paola Vitry; Arnauld Galbois; Hafid Ait-Oufella; Jean-Luc Baudel; Bertrand Guidet; Georges Offenstadt
Journal:  Ann Intensive Care       Date:  2012-06-14       Impact factor: 6.925
View more
  5 in total

1.  Short acting insulin analogues in intensive care unit patients.

Authors:  Federico Bilotta; Carolina Guerra; Rafael Badenes; Simona Lolli; Giovanni Rosa
Journal:  World J Diabetes       Date:  2014-06-15

2.  The responsibility of undertaking large randomized controlled trials.

Authors:  Jean-Charles Preiser; Jan Wernerman
Journal:  Intensive Care Med       Date:  2014-01-14       Impact factor: 17.440

3.  Tight computerized versus conventional glucose control in the ICU: a randomized controlled trial.

Authors:  Pierre Kalfon; Bruno Giraudeau; Carole Ichai; Alexandre Guerrini; Nicolas Brechot; Raphaël Cinotti; Pierre-François Dequin; Béatrice Riu-Poulenc; Philippe Montravers; Djilalli Annane; Hervé Dupont; Michel Sorine; Bruno Riou
Journal:  Intensive Care Med       Date:  2014-01-14       Impact factor: 17.440

4.  Year in review in Intensive Care Medicine 2013: I. Acute kidney injury, ultrasound, hemodynamics, cardiac arrest, transfusion, neurocritical care, and nutrition.

Authors:  Giuseppe Citerio; Jan Bakker; Matteo Bassetti; Dominique Benoit; Maurizio Cecconi; J Randall Curtis; Glenn Hernandez; Margaret Herridge; Samir Jaber; Michael Joannidis; Laurent Papazian; Mark Peters; Pierre Singer; Martin Smith; Marcio Soares; Antoni Torres; Antoine Vieillard-Baron; Jean-François Timsit; Elie Azoulay
Journal:  Intensive Care Med       Date:  2013-12-13       Impact factor: 17.440

Review 5.  Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine.

Authors:  M Joannidis; W Druml; L G Forni; A B J Groeneveld; P M Honore; E Hoste; M Ostermann; H M Oudemans-van Straaten; M Schetz
Journal:  Intensive Care Med       Date:  2017-06-02       Impact factor: 17.440
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.